Horizon Therapeutics Public Limited Company DSO Ratio 2011-2026 | HZNP

Annual DSO Ratio Horizon Therapeutics Public Limited Company

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
65.8	73.1	88.6	115	140	140	114	101	90.9	56.7	55.6	126

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
140	55.6	97.3

Quarterly DSO Ratio Horizon Therapeutics Public Limited Company

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
64.8	71.3	-	31.9	35.6	67.9	-	66.5	64.6	147	80.8	94.6	130	137	103	111	116	142	119	130	140	177	135	136	128	147	89.9	134	108	115	78.5	84.8	111	115	65	89.8	102	79	48.4	60.4	131	102	49.7	50	82.3	106	61.4	793	162	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
793	31.9	115

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
ACADIA Pharmaceuticals ACAD	37.5	$ 22.5	1.86 %	$ 3.73 B	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Alnylam Pharmaceuticals ALNY	58.1	$ 327.16	2.39 %	$ 42.9 B	USA
Amgen AMGN	81.2	$ 349.22	2.71 %	$ 188 B	USA
Amphastar Pharmaceuticals AMPH	70.9	$ 20.4	-0.87 %	$ 954 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Aquestive Therapeutics AQST	103	$ 4.18	1.33 %	$ 447 M	USA
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Arcutis Biotherapeutics ARQT	106	$ 24.57	5.59 %	$ 3.13 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Autolus Therapeutics plc AUTL	58.2	$ 1.48	8.46 %	$ 394 M	Britain
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.85	2.41 %	$ 9.26 B	Australia
CymaBay Therapeutics CBAY	182	-	-	$ 3.45 B	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Aytu BioScience AYTU	150	$ 2.71	5.51 %	$ 17 M	USA
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	2.26 K	-	-	$ 1.41 B	USA
Can-Fite BioPharma Ltd. CANF	28.1	$ 3.06	0.99 %	$ 6.66 B	Israel
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
Cerus Corporation CERS	47	$ 1.9	2.99 %	$ 362 M	USA
Coherus BioSciences CHRS	559	$ 1.7	1.8 %	$ 199 M	USA
CollPlant Biotechnologies Ltd. CLGN	9.68	$ 0.36	0.28 %	$ 4.12 M	Israel
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Concert Pharmaceuticals CNCE	147	-	-	$ 401 M	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Catalyst Pharmaceuticals CPRX	59.5	$ 25.57	2.3 %	$ 3.13 B	USA
CTI BioPharma Corp. CTIC	52.1	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Cyclacel Pharmaceuticals CYCCP	3.66 K	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	60.8	-	-	$ 2.18 B	USA